BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1058 related articles for article (PubMed ID: 28718050)

  • 1. Dissolving Microneedle Patches for Dermal Vaccination.
    Leone M; Mönkäre J; Bouwstra JA; Kersten G
    Pharm Res; 2017 Nov; 34(11):2223-2240. PubMed ID: 28718050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microneedles for vaccine delivery: challenges and future perspectives.
    Shin CI; Jeong SD; Rejinold NS; Kim YC
    Ther Deliv; 2017 Jun; 8(6):447-460. PubMed ID: 28530151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microneedle Patches as Drug and Vaccine Delivery Platform.
    Li J; Zeng M; Shan H; Tong C
    Curr Med Chem; 2017; 24(22):2413-2422. PubMed ID: 28552053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A low-invasive and effective transcutaneous immunization system using a novel dissolving microneedle array for soluble and particulate antigens.
    Matsuo K; Yokota Y; Zhai Y; Quan YS; Kamiyama F; Mukai Y; Okada N; Nakagawa S
    J Control Release; 2012 Jul; 161(1):10-7. PubMed ID: 22306332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multilayered pyramidal dissolving microneedle patches with flexible pedestals for improving effective drug delivery.
    Lau S; Fei J; Liu H; Chen W; Liu R
    J Control Release; 2017 Nov; 265():113-119. PubMed ID: 27574991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan-based dissolving microneedles with high antigen content for intradermal vaccination: Formulation, physicochemical characterization and immunogenicity assessment.
    Leone M; Priester MI; Romeijn S; Nejadnik MR; Mönkäre J; O'Mahony C; Jiskoot W; Kersten G; Bouwstra JA
    Eur J Pharm Biopharm; 2019 Jan; 134():49-59. PubMed ID: 30453025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rabies vaccination in dogs using a dissolving microneedle patch.
    Arya JM; Dewitt K; Scott-Garrard M; Chiang YW; Prausnitz MR
    J Control Release; 2016 Oct; 239():19-26. PubMed ID: 27524283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parameter optimization toward optimal microneedle-based dermal vaccination.
    van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
    Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.
    An M; Liu H
    Small; 2017 Jul; 13(26):. PubMed ID: 28544329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microneedle technologies for (trans)dermal drug and vaccine delivery.
    van der Maaden K; Jiskoot W; Bouwstra J
    J Control Release; 2012 Jul; 161(2):645-55. PubMed ID: 22342643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccine.
    Hong X; Wei L; Wu F; Wu Z; Chen L; Liu Z; Yuan W
    Drug Des Devel Ther; 2013; 7():945-52. PubMed ID: 24039404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced Stability of Inactivated Influenza Vaccine Encapsulated in Dissolving Microneedle Patches.
    Chu LY; Ye L; Dong K; Compans RW; Yang C; Prausnitz MR
    Pharm Res; 2016 Apr; 33(4):868-78. PubMed ID: 26620313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissolving undercut microneedle arrays for multicomponent cutaneous vaccination.
    Balmert SC; Carey CD; Falo GD; Sethi SK; Erdos G; Korkmaz E; Falo LD
    J Control Release; 2020 Jan; 317():336-346. PubMed ID: 31756393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diphtheria toxoid dissolving microneedle vaccination: Adjuvant screening and effect of repeated-fractional dose administration.
    Leone M; Romeijn S; Du G; Le Dévédec SE; Vrieling H; O'Mahony C; Bouwstra JA; Kersten G
    Int J Pharm; 2020 Apr; 580():119182. PubMed ID: 32119899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of PLGA nanoparticle loaded dissolving microneedles and comparison with hollow microneedles in intradermal vaccine delivery.
    Mönkäre J; Pontier M; van Kampen EEM; Du G; Leone M; Romeijn S; Nejadnik MR; O'Mahony C; Slütter B; Jiskoot W; Bouwstra JA
    Eur J Pharm Biopharm; 2018 Aug; 129():111-121. PubMed ID: 29803720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of novel double-decker microneedle patches for transcutaneous vaccine delivery.
    Ono A; Azukizawa H; Ito S; Nakamura Y; Asada H; Quan YS; Kamiyama F; Katayama I; Hirobe S; Okada N
    Int J Pharm; 2017 Oct; 532(1):374-383. PubMed ID: 28855138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcutaneous immunization of Streptococcus suis bacterin using dissolving microneedles.
    Hsueh KJ; Chen MC; Cheng LT; Lee JW; Chung WB; Chu CY
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():78-87. PubMed ID: 28131383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing.
    Rajabi M; Roxhed N; Shafagh RZ; Haraldson T; Fischer AC; Wijngaart WV; Stemme G; Niklaus F
    PLoS One; 2016; 11(12):e0166330. PubMed ID: 27935976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microneedles: A smart approach and increasing potential for transdermal drug delivery system.
    Waghule T; Singhvi G; Dubey SK; Pandey MM; Gupta G; Singh M; Dua K
    Biomed Pharmacother; 2019 Jan; 109():1249-1258. PubMed ID: 30551375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering Microneedle Patches for Vaccination and Drug Delivery to Skin.
    Prausnitz MR
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():177-200. PubMed ID: 28375775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.